Murakami Yoshiaki

Affiliation and department：
Research theme for competitive and other funds (7)：

2015 - 2017 膵癌患者の末梢血検体におけるcell-free DNA KRAS遺伝子変異の研究
2012 - 2014 胆管癌の抗癌剤代謝関連酵素発現と感受性解析による個別化治療の確立
2009 - 2011 Analysis of telomere and telomerase activation mechanism in pancreatic neoplasms for molecularly targeted therapy
2005 - 2006 Clarification of promoting effect on engraftment of intraportally transplanted islet cells under hepatic regeneration
2004 - 2005 Does hepatic regeneration promotes engraftment of intraportally transplanted islet cells?

Show all

Papers (537)：

Kazuhiro Toyota, Yoshiaki Murakami, Naru Kondo, Kenichiro Uemura, Naoya Nakagawa, Shinya Takahashi, Taijiro Sueda. Impact of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression on Prognosis After Surgical Resection for Biliary Carcinoma. JOURNAL OF GASTROINTESTINAL SURGERY. 2017. 21. 6. 990-999
Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Naru Kondo, Naoya Nakagawa, Kenjiro Okada, Shinya Takahashi, Taijiro Sueda. Prognostic impact of normalization of serum tumor markers following neoadjuvant chemotherapy in patients with borderline resectable pancreatic carcinoma with arterial contact. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017. 79. 4. 801-811
Naru Kondo, Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Naoya Nakagawa, Shinya Takahashi, Hiroki Ohge, Taijiro Sueda. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017. 79. 4. 775-781
K. Uemura, S. Satoi, F. Motoi, M. Kwon, M. Unno, Y. Murakami. Randomized clinical trial of duct-to-mucosa pancreaticogastrostomy versus handsewn closure after distal pancreatectomy. BRITISH JOURNAL OF SURGERY. 2017. 104. 5. 536-543
Naru Kondo, Yoshiaki Murakami, Kenichiro Uemura, Naoya Nakagawa, Shinya Takahashi, Hiroki Ohge, Taijiro Sueda. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma. PANCREATOLOGY. 2017. 17. 1. 95-102

ｍore...

Lectures and oral presentations (47)：

術前術後補助化学療法を用いたBorderline resectable(BR)膵癌の治療成績と問題点
(第78回日本臨床外科学会総会 2016)
術前化学療法後切除を施行した動脈接触膵癌におけるR0 切除の意義
(第11回膵癌術前治療研究会 2016)
予後不良因子を有する進行胆道癌に対する術後GS(Gemcitabine+S-1)補助化学療法の効果
(第52回日本胆道学会学術集会 2016)
動脈接触局所進行(LAPC-A)膵癌に対し術前化学療法後動脈合併切除は許容されるか?
(第43回日本膵切研究会 2016)
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy for pancreatic carcinoma
(第71回日本消化器外科学会総会 2016)

ｍore...

Awards (2)：

2013/03 - 平成24年度広島大学医歯薬保健学研究院優秀教官賞
2012/11 - 広島臨床外科医学会賞

Association Membership(s) (7)：

Japanese Society for Abdominal Emergency Medicine , 日本膵臓学会 , 日本胆道学会 , 日本肝胆膵外科学会 , 日本臨床外科学会 , 日本消化器外科学会 , 日本外科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page